Cytomedix Inc - MD Montgomery, Gaithersburg 20877

Cytomedix Inc entered the industry of Biological Research in 1998 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 3391120, which describes it as a Biological Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Biological Research. The business provides service to the B2B market.

To acquire more information, please contact Martin Rosendale, Chief Executive Officer by calling (240) 499-2680 during business hours. You can also write to the business’ Headquarters at 209 Perry Parkway # 7, Gaithersburg, Maryland MD 20877. You can also visit the company’s website at cytomedix.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Cytomedix Inc
Representative: Martin Rosendale, Chief Executive Officer
Place of Business: 209 Perry Parkway # 7, Gaithersburg, MD 20877
Contact Number: (240) 499-2680
Website: cytomedix.com
Type of Service: Biological Research
SIC Number: 8731
NAICS Number: 3391120
Locality: Headquarters
Market Type: B2B (Business to Business)
Began: 1998
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Cytomedix Inc is a company operating from Montgomery, Maryland providing professional Biological Research and relevant B2B variables. It was founded in 1998 and registered with the SIC code 8731 as Biological Research, and with the NAICS code 3391120 as Biological Research.

With a current employee count of 1 to 4, Cytomedix Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Martin Rosendale, Chief Executive Officer at (240) 499-2680 for related queries, or to locate its Headquarters using the coordinates 39.14302,-77.21.

The Headquarters can also be found at the street address 209 Perry Parkway # 7 in Gaithersburg, Maryland 20877 and can be engaged online through the company website at cytomedix.com, the company Twitter , and Facebook page .